Oct 7 (Reuters) – The pharmaceutical industry’s top lobby group on Wednesday sued to invalidate one piece of the Trump administration’s efforts to benchmark US drug prices to lower costs overseas in the Medicare health insurance program, arguing that it is an illegal overreach by the US government.
The GLOBE rule intends to set hospital drug prices for Medicare patients. Its final version was published last week on exactly how a “most favored nation” pricing system based on what is paid in a group of comparable countries would be integrated in the Medicare Part B program.
The Phrase lobby group filed its lawsuit against Health Secretary Robert F. Kennedy Jr., the US Department of Health and Human Services, CMS Administrator Meme Oz, CMS, CMS’ Center for Medicare and Medicaid Innovation, and CMMI’s Director Abe Sutton in the US District Court for the District of Columbia on Wednesday morning.
(Reporting by Michael Erman and Jonathan Stempel in New York; Editing by Bill Berkrot)
Brought to you by www.srnnews.com
SRN News — View the original story at SRNNews.com.
